Manufacturer
Janssen (Johnson & Johnson) NDC Codes
Finished products listed with the FDA under labeler names that contain “Janssen”.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Risperdalrisperidone | Risperidone 3 mg/1 | TabletOral | Janssen Pharmaceuticals, Inc. | 50458-330 |
| Risperdalrisperidone | Risperidone 4 mg/1 | TabletOral | Janssen Pharmaceuticals, Inc. | 50458-350 |
| Risperdal Constarisperidone | — | Kit | Janssen Pharmaceuticals, Inc. | 50458-306 |
| Risperdal Constarisperidone | — | Kit | Janssen Pharmaceuticals, Inc. | 50458-307 |
| Risperdal Constarisperidone | — | Kit | Janssen Pharmaceuticals, Inc. | 50458-308 |
| Risperdal Constarisperidone | — | Kit | Janssen Pharmaceuticals, Inc. | 50458-309 |
| Risperdal M-Tabrisperidone | Risperidone 1 mg/1 | Tablet, Orally disintegratingOral | Janssen Pharmaceuticals, Inc. | 50458-315 |
| Risperdal M-Tabrisperidone | Risperidone 2 mg/1 | Tablet, Orally disintegratingOral | Janssen Pharmaceuticals, Inc. | 50458-325 |
| Risperdal M-Tabrisperidone | Risperidone 3 mg/1 | Tablet, Orally disintegratingOral | Janssen Pharmaceuticals, Inc. | 50458-335 |
| Risperdal M-Tabrisperidone | Risperidone 4 mg/1 | Tablet, Orally disintegratingOral | Janssen Pharmaceuticals, Inc. | 50458-355 |
| Risperdal M-Tabrisperidone | Risperidone .5 mg/1 | Tablet, Orally disintegratingOral | Janssen Pharmaceuticals, Inc. | 50458-395 |
| Risperidone | Risperidone 1 mg/mL | SolutionOral | Janssen Pharmaceuticals, Inc. | 50458-596 |
| Rybrevantamivantamab-vmjw | Amivantamab 350 mg/1 | InjectionIntravenous | Janssen Biotech, Inc. | 57894-501 |
| Rybrevant Fasproamivantamab and hyaluronidase-lpuj (human recombinant) | Amivantamab 1600 mg/10mL; Hyaluronidase (Human recombinant) 20000 mg/10mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-510 |
| Rybrevant Fasproamivantamab and hyaluronidase-lpuj (human recombinant) | Amivantamab 2240 mg/14mL; Hyaluronidase (Human recombinant) 28000 mg/14mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-514 |
| Rybrevant Fasproamivantamab and hyaluronidase-lpuj (human recombinant) | Amivantamab 2400 mg/15mL; Hyaluronidase (Human recombinant) 30000 mg/15mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-515 |
| Rybrevant Fasproamivantamab and hyaluronidase-lpuj (human recombinant) | Amivantamab 3520 mg/22mL; Hyaluronidase (Human recombinant) 44000 mg/22mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-522 |
| Simponigolimumab | Golimumab 50 mg/.5mL | Injection, SolutionSubcutaneous | Janssen Biotech, Inc. | 57894-070 |
| Simponigolimumab | Golimumab 100 mg/mL | Injection, SolutionSubcutaneous | Janssen Biotech, Inc. | 57894-071 |
| Simponi Ariagolimumab | Golimumab 50 mg/4mL | SolutionIntravenous | Janssen Biotech, Inc. | 57894-350 |
| Sirturobedaquiline fumarate | Bedaquiline fumarate 100 mg/1 | TabletOral | Janssen Products, LP | 59676-701 |
| Sirturobedaquiline fumarate | Bedaquiline fumarate 20 mg/1 | TabletOral | Janssen Products, LP | 59676-702 |
| Sporanoxitraconazole | Itraconazole 100 mg/1 | CapsuleOral | Janssen Pharmaceuticals, Inc. | 50458-290 |
| Spravatoesketamine hydrochloride | Esketamine hydrochloride 28 mg/.2mL | SolutionNasal | Janssen Pharmaceuticals, Inc. | 50458-028 |
| Stelaraustekinumab | Ustekinumab 130 mg/26mL | SolutionIntravenous | Janssen Biotech, Inc. | 57894-054 |